Future studies of Ubqln2-mediated ALS will apply quantitative global proteomics to patient-derived samples, and explore the potential effects of TRIM32, PEG10, and RTL8 on neuronal function. This evidence concerns the gene UBQLN2 and amyotrophic lateral sclerosis.